Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast CancerVanessa F. Merino, Saraswati Sukumar, Soonweng Cho et al.|Cancer Research|2016Cited by 48
Abstract 123: Enhanced anti-tumor activity of the combination of entinostat and NKTR214 in renal and colon cancer tumor modelsLei Wang, Jonathan Zalevsky, Fei Chen et al.|Cancer Research|2018Cited by 1